Correlation Between Unibel SA and OSE Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unibel SA and OSE Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unibel SA and OSE Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unibel SA and OSE Pharma SA, you can compare the effects of market volatilities on Unibel SA and OSE Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unibel SA with a short position of OSE Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unibel SA and OSE Pharma.

Diversification Opportunities for Unibel SA and OSE Pharma

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Unibel and OSE is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Unibel SA and OSE Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OSE Pharma SA and Unibel SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unibel SA are associated (or correlated) with OSE Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OSE Pharma SA has no effect on the direction of Unibel SA i.e., Unibel SA and OSE Pharma go up and down completely randomly.

Pair Corralation between Unibel SA and OSE Pharma

Assuming the 90 days trading horizon Unibel SA is expected to generate 4.0 times less return on investment than OSE Pharma. But when comparing it to its historical volatility, Unibel SA is 2.72 times less risky than OSE Pharma. It trades about 0.02 of its potential returns per unit of risk. OSE Pharma SA is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  636.00  in OSE Pharma SA on October 30, 2024 and sell it today you would earn a total of  5.00  from holding OSE Pharma SA or generate 0.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy68.79%
ValuesDaily Returns

Unibel SA  vs.  OSE Pharma SA

 Performance 
       Timeline  
Unibel SA 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Unibel SA are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Unibel SA sustained solid returns over the last few months and may actually be approaching a breakup point.
OSE Pharma SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OSE Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Unibel SA and OSE Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unibel SA and OSE Pharma

The main advantage of trading using opposite Unibel SA and OSE Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unibel SA position performs unexpectedly, OSE Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OSE Pharma will offset losses from the drop in OSE Pharma's long position.
The idea behind Unibel SA and OSE Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas